Alnylam Turns To Value-Based Pricing Again For Oxlumo

 
• By Joseph Haas
  
FDA Approved
Alnylam's third FDA approval is the first drug therapy for PH1
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip